WaveMedix

Intelligent agentic systems for real-world decision support

Wavemedix founded in spring 2025 addresses the multi-billion-dollar market at the intersection of cardiology, pharmaceuticals, and regulated medical AI, by combining patented signal tokenization, interpretable reinforcement learning, local LLM technology, and a leadership team with a proven record of successful exits.